IT WAS REPORTED THAT POST-CORONARY DRUG ELUTING STENTING TREATMENT PROCEDURE, VERY LATE STENT THROMBOSIS AND MYOCARDIAL INFARCTION OCCURRED. TARGET LESION LOCATION AND LESION CHARACTERISTICS WERE NOT PROVIDED. PREVIOUSLY THE PATIENT UNDERWENT A STENTING PROCEDURE WITH AN UNSPECIFIED TAXUS EXPRESS2 STENT. AT SOME POINT POST-PROCEDURE, THE PATIENT EXPERIENCED MYOCARDIAL INFARCTION AND VERY LATE STENT THROMBOSIS WAS OBSERVED. NO FURTHER INFORMATION WAS PROVIDED.
